Experienced in Autosomal Dominant Partial Epilepsy with Auditory Features

Dr. Rhonna S. Shatz

Neurology
University Of Cincinnati Physicians Company LLC
2123 Auburn Ave, 
Cincinnati, OH 
Accepting New Patients
Offers Telehealth
43 Years of Experience
Experienced in Autosomal Dominant Partial Epilepsy with Auditory Features
University Of Cincinnati Physicians Company LLC
2123 Auburn Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rhonna Shatz is a Neurologist in Cincinnati, Ohio. Dr. Shatz has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Partial Epilepsy with Auditory Features. Her top areas of expertise are Lewy Body Dementia (LBD), Cerebellar Degeneration, Frontotemporal Dementia, and Primary Progressive Aphasia. Dr. Shatz is currently accepting new patients.

Her clinical research consists of co-authoring 14 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Neurology
Licenses
Psychiatry & Neurology in MI
Hospital Affiliations
West Chester Hospital
University Of Cincinnati Medical Center, LLC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY LLC
2123 Auburn Ave, Cincinnati, OH 45219
Other Locations
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY LLC
7690 Discovery Dr, West Chester, OH 45069

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Enrollment Status: Completed
Publish Date: September 07, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 3
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

14 Total Publications

Association of plasma concentration of trace metals with frontotemporal degeneration.
Association of plasma concentration of trace metals with frontotemporal degeneration.
Journal: Frontiers in neurology
Published: March 14, 2025
Similar Doctors
Distinguished in Autosomal Dominant Partial Epilepsy with Auditory Features
Dr. Maureen Li
Neurology
Distinguished in Autosomal Dominant Partial Epilepsy with Auditory Features
Dr. Maureen Li
Neurology

Riverhills Healthcare Inc

4805 Montgomery Road, Ste. 150, 
Cincinnati, OH 
 (4.3 miles away)
513-961-5558
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Maureen Li is a Neurologist in Cincinnati, Ohio. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Autosomal Dominant Partial Epilepsy with Auditory Features. Her top areas of expertise are Autosomal Dominant Partial Epilepsy with Auditory Features, Memory Loss, Seizures, and Migraine. Dr. Li is currently accepting new patients.

Distinguished in Autosomal Dominant Partial Epilepsy with Auditory Features
Dr. David M. Ficker
Neurology
Distinguished in Autosomal Dominant Partial Epilepsy with Auditory Features
Dr. David M. Ficker
Neurology

University Of Cincinnati Physicians Company LLC

222 Piedmont Ave, 
Cincinnati, OH 
 (1.1 miles away)
513-475-7855
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Ficker is a Neurologist in Cincinnati, Ohio. Dr. Ficker is rated as a Distinguished provider by MediFind in the treatment of Autosomal Dominant Partial Epilepsy with Auditory Features. His top areas of expertise are Seizures, Memory Loss, Dravet Syndrome, Landau-Kleffner Syndrome, and Gastrostomy. Dr. Ficker is currently accepting new patients.

Distinguished in Autosomal Dominant Partial Epilepsy with Auditory Features
Dr. Mark A. Callow
Neurology
Distinguished in Autosomal Dominant Partial Epilepsy with Auditory Features
Dr. Mark A. Callow
Neurology

University Of Cincinnati Physicians Company LLC

7700 University Dr, 
West Chester, OH 
 (18.1 miles away)
513-298-7325
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Callow is a Neurologist in West Chester, Ohio. Dr. Callow is rated as a Distinguished provider by MediFind in the treatment of Autosomal Dominant Partial Epilepsy with Auditory Features. His top areas of expertise are Seizures, Memory Loss, Landau-Kleffner Syndrome, Dravet Syndrome, and Gastrostomy. Dr. Callow is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shatz's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 79 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile